Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription 03.11.2025 4 Am J Cardiol 2 Am J Med 6 Angiology 1 Ann Intern Med 1 Ann Thorac Surg 1 Arterioscler Thromb Vasc Biol 2 Circ Cardiovasc Imaging 2 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 2 Circ J 2 Circulation 2 Eur Heart J 1 Hypertension 4 J Am Coll Cardiol 1 J Cardiovasc Pharmacol 1 J Mol Cell Cardiol 2 J Thorac Cardiovasc Surg 1 JAMA 8 Lancet 1 Mol Cell Biochem 1 N Engl J Med 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. AKBAR UA, Maqsood H, Shah AR, Kleiman NS, et al
   Outcomes of Percutaneous Coronary Intervention for Cardiogenic Shock after Coronary Artery Bypass Graft.
   Am J Cardiol. 2025 Oct 27:S0002-9149(25)00646.
   PubMed         Abstract available
   
   
2. CARVALHO PEP, Strepkos D, Alexandrou M, Mutlu D, et al
   Mini-Crush Versus Double Kissing Crush in Bifurcation Percutaneous Coronary Intervention: Insights from PROGRESS-BIFURCATION registry.
   Am J Cardiol. 2025 Oct 23:S0002-9149(25)00663.
   PubMed         Abstract available
   
   
3. SELLA G, Kharsa C, Sammour YM, Chaaya RGB, et al
   The Obesity Paradox in Chronic Total Occlusion Percutaneous Coronary Intervention: Contemporary Outcomes Across Body Mass Index Categories.
   Am J Cardiol. 2025 Oct 22:S0002-9149(25)00640.
   PubMed         Abstract available
   
   
4. VAN OORT MJH, Phagu AAS, Oliveri F, Bingen BO, et al
   Clinical and Technical Predictors of Adverse Cardiovascular Events Following Coronary Lithotripsy in the BENELUX-IVL Registry.
   Am J Cardiol. 2025 Oct 22:S0002-9149(25)00656.
   PubMed         Abstract available
   
   

   
   Am J Med

5. REN M, Zhang J, Chi M
   Iron Supplementation May Become a New Option for the Treatment of Cardiovascular Disease.
   Am J Med. 2025;138:e245.
   PubMed        
   
   
6. LIAO Y, Liu S, Lv X
   A Broader Perspective on the Link Between Biological Aging and Cardiovascular Disease in Older Adults With Hypertension.
   Am J Med. 2025;138:e243.
   PubMed        
   
   

   
   Angiology

7. ZORLU C, Demirezen Y, Karaman K, Karayakali M, et al
   Evaluation of Long-Term Cardiovascular Outcomes in Patients With NSTEMI Undergoing Percutaneous Coronary Intervention: Impact of Comorbid Peripheral Artery Disease.
   Angiology. 2025 Oct 24:33197251382399. doi: 10.1177/00033197251382399.
   PubMed         Abstract available
   
   
8. SERIN E, Sahin S, Gurdal A, Sarilar M, et al
   Prognostic Value of the Naples Score in Older Patients With Acute Coronary Syndrome.
   Angiology. 2025 Oct 24:33197251383351. doi: 10.1177/00033197251383351.
   PubMed         Abstract available
   
   
9. SAHIN YB, Kiziltunc E, Candemir M
   R2CHADS2 Score: An Effective Risk Stratification Tool for Contrast-Induced Nephropathy and Cardiovascular Outcomes in STEMI Patients Undergoing PCI.
   Angiology. 2025 Oct 24:33197251383333. doi: 10.1177/00033197251383333.
   PubMed         Abstract available
   
   
10. KIVRAK U, Unkun T
    Evaluation of Cardiovascular Risk Scores and their Association With Vascular Structural Changes in Patients With Retinal Vein Occlusion.
    Angiology. 2025 Oct 31:33197251379119. doi: 10.1177/00033197251379119.
    PubMed         Abstract available
    
    
11. DOU JJ, Wang HQ, Li F
    Letter: Role of Triglycerides-Glucose Index in Patients With Acute Coronary Syndrome.
    Angiology. 2025 Oct 31:33197251390071. doi: 10.1177/00033197251390071.
    PubMed        
    
    
12. REN LY, Li M, Hu HL
    Letter: C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index as a Novel Biomarker of Prognosis in Patients With Cardiovascular Disease.
    Angiology. 2025 Oct 31:33197251390084. doi: 10.1177/00033197251390084.
    PubMed        
    
    

    
    Ann Intern Med

13. DEL POZO CRUZ B, Ahmadi M, Sabag A, Saint Maurice PF, et al
    Step Accumulation Patterns and Risk for Cardiovascular Events and Mortality Among Suboptimally Active Adults.
    Ann Intern Med. 2025 Oct 28. doi: 10.7326/ANNALS-25-01547.
    PubMed         Abstract available
    
    

    
    Ann Thorac Surg

14. SQUIERS JJ, Shih E, DiMaio JM, Banwait JK, et al
    All-Venous Grafting and Very-Long-Term Survival after Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2025 Oct 22:S0003-4975(25)00998.
    PubMed         Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

15. POLKINGHORNE MD, Badi I, Baragetti A, Chauhan J, et al
    Lipoprotein(a) and Vascular Redox State in Patients With Advanced Coronary Atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2025 Oct 30. doi: 10.1161/ATVBAHA.125.322924.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Imaging

16. MAGALHAES TA
    Coronary Microvascular Dysfunction and Myocardial Fibrosis: A Tomographic Look at a Hidden Entity.
    Circ Cardiovasc Imaging. 2025 Oct 27:e019082.
    PubMed        
    
    
17. HAYS AG, Kelle S
    Mental Stress, Significant Sex Differences, and the Substrate for Cardiovascular Disease: Early Insights From CMR.
    Circ Cardiovasc Imaging. 2025 Oct 27:e019081.
    PubMed        
    
    

    
    Circ Cardiovasc Interv

18. IKEDA K, Mizukami T, Sakai K, Bouisset F, et al
    Impact of Pullback Pressure Gradient on Clinical Outcomes after Percutaneous Coronary Interventions.
    Circ Cardiovasc Interv. 2025 Oct 25. doi: 10.1161/CIRCINTERVENTIONS.125.016022.
    PubMed         Abstract available
    
    
19. KIYOHARA Y, Aikawa T, Saito T, Casso Dominguez A, et al
    Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials.
    Circ Cardiovasc Interv. 2025 Oct 27:e016005.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

20. NALLAMOTHU BK, Gluckman T
    Intersection of Payer Coverage Policies and Clinical Care: Striking the Right Balance in Cardiovascular Medicine.
    Circ Cardiovasc Qual Outcomes. 2025 Oct 27:e012925.
    PubMed        
    
    

    
    Circ J

21. KUWABARA M, Yamamoto T, Tahara Y, Kikuchi M, et al
    Utilization of Intensive Care Units and Outcomes Based on Admission Wards in Cardiovascular Emergencies.
    Circ J. 2025;89:1804-1812.
    PubMed         Abstract available
    
    
22. YOSHIMURA S, Arimoto K, Nishikita H, Fushimura Y, et al
    Rationale, Design, Feasibility, and Profile of the Japanese Circulation Society Chest Pain Registry?- Single-Center Pilot Study.
    Circ J. 2025;89:1740-1751.
    PubMed         Abstract available
    
    

    
    Circulation

23. GRECO M, Lombardi G, Brusasco C, Pieri M, et al
    Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial.
    Circulation. 2025 Jun 13. doi: 10.1161/CIRCULATIONAHA.125.075254.
    PubMed         Abstract available
    
    
24. RUEL M
    Introduction to the 2025 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2025;152:1187.
    PubMed        
    
    

    
    Eur Heart J

25. MONTONE RA, Cosentino N, Gorla R, Biscaglia S, et al
    Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial.
    Eur Heart J. 2025 Oct 28:ehaf917. doi: 10.1093.
    PubMed         Abstract available
    
    
26. AYYAD M, Albandak M, Allencherril J
    Reclassifying myocardial infarction: from ST elevation to coronary occlusion.
    Eur Heart J. 2025 Oct 30:ehaf825. doi: 10.1093.
    PubMed        
    
    

    
    Hypertension

27. WANG W, Zhao H, Han X, Li J, et al
    Sex-Specific Trajectories of Arterial Stiffness and Major Adverse Cardiovascular Events.
    Hypertension. 2025 Oct 28. doi: 10.1161/HYPERTENSIONAHA.125.25098.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

28. YANG E, Ferdinand KC
    Ushering in a New Approach for Primary Prevention: Guidelines for Assessing Cardiovascular Risk.
    J Am Coll Cardiol. 2025;86:1532-1535.
    PubMed        
    
    
29. WU Y, Neal B, Miranda JJ, Labarthe D, et al
    Salt Substitution for Hypertension and Cardiovascular Disease Prevention: The SSaSS Trial and Beyond.
    J Am Coll Cardiol. 2025;86:1504-1506.
    PubMed        
    
    
30. DE WINTER RW, Hoek R, Walsh SJ, Hanratty CG, et al
    PCI of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery: A Multicenter, Randomized Trial.
    J Am Coll Cardiol. 2025 Oct 28:S0735-1097(25)09477.
    PubMed         Abstract available
    
    
31. MASRI A, Judge DP, Ruberg FL, Gillmore JD, et al
    Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CM.
    J Am Coll Cardiol. 2025 Sep 28:S0735-1097(25)07774.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

32. KHATAMI S, Faghihi M, Zarrin A, Sarveazad A, et al
    Cardioprotective Effects of Apelin in Myocardial Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis.
    J Cardiovasc Pharmacol. 2025 Oct 28. doi: 10.1097/FJC.0000000000001773.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

33. SHUMLIAKIVSKA M, Fischer A, Muhly-Reinholz M, Leonard VE, et al
    The long non-coding RNA Snhg15 protects the heart after myocardial infarction.
    J Mol Cell Cardiol. 2025 Oct 27:S0022-2828(25)00195.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

34. PATLOLLA SH, Crestanello JA, Schaff HV, Lahr BD, et al
    Changes in Ejection Fraction After Coronary Artery Bypass Grafting for Ischemic Cardiomyopathy: Impact on Survival and Determinants of Improvement.
    J Thorac Cardiovasc Surg. 2025 Oct 29:S0022-5223(25)00957.
    PubMed         Abstract available
    
    
35. JAGGERS J, Winlaw D, Fuller S, Sethi N, et al
    Corrigendum to "2025 American Association for Thoracic Surgery Congenital Cardiac Surgery Working Group-Expert consensus document on the management of patients with pulmonary atresia with intact ventricular septum" (Journal of Thoracic and Cardiovascu
    J Thorac Cardiovasc Surg. 2025 Oct 26:S0022-5223(25)00766.
    PubMed        
    
    

    
    JAMA

36. ABBASI J
    New Guidance on Cardiovascular Disease and COVID-19-From Infection to Long COVID to Vaccination.
    JAMA. 2025 Oct 24. doi: 10.1001/jama.2025.18834.
    PubMed        
    
    

    
    Lancet

37. DEANFIELD J, Lincoff AM, Kahn SE, Emerson SS, et al
    Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial.
    Lancet. 2025 Oct 22:S0140-6736(25)01375-3. doi: 10.1016/S0140-6736(25)01375.
    PubMed         Abstract available
    
    
38. HON JJ, Hon JKF
    Plant-based diets for coronary artery disease prevention.
    Lancet. 2025;406:1946-1947.
    PubMed        
    
    
39. ZHOU T
    Drug-coated balloon angioplasty and stenting for coronary artery lesions.
    Lancet. 2025;406:1948-1949.
    PubMed        
    
    
40. LIM PO
    Drug-coated balloon angioplasty and stenting for coronary artery lesions.
    Lancet. 2025;406:1949.
    PubMed        
    
    
41. SPAULDING C, Eccleshall S, Krackhardt F, Urban P, et al
    Drug-coated balloon angioplasty and stenting for coronary artery lesions.
    Lancet. 2025;406:1949-1950.
    PubMed        
    
    
42. GURGOGLIONE FL, Cortese B
    Drug-coated balloon angioplasty and stenting for coronary artery lesions.
    Lancet. 2025;406:1950.
    PubMed        
    
    
43. RISSANEN TT, Eccleshall S, Jeger R, Latib A, et al
    Drug-coated balloon angioplasty and stenting for coronary artery lesions.
    Lancet. 2025;406:1950-1951.
    PubMed        
    
    
44. GAO C, Onuma Y, Serruys PW, Tao L, et al
    Drug-coated balloon angioplasty and stenting for coronary artery lesions - Authors' reply.
    Lancet. 2025;406:1951-1952.
    PubMed        
    
    

    
    Mol Cell Biochem

45. AHMADI P, Akbarzadeh S, Alizadeh M, Mohammadi N, et al
    Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.
    Mol Cell Biochem. 2025;480:5793-5803.
    PubMed         Abstract available
    
    

    
    N Engl J Med

46. NIJVELDT R, Maeng M, Beijnink CWH, Piek JJ, et al
    Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction.
    N Engl J Med. 2025 Oct 28. doi: 10.1056/NEJMoa2512918.
    PubMed         Abstract available
    
    

    
    PLoS One

47. SAITO Y, Mori Y, Yamaji K, Kohsaka S, et al
    Geographic variations and trends in percutaneous intervention for patients with and without acute myocardial infarction: A Japanese nationwide registry study.
    PLoS One. 2025;20:e0335426.
    PubMed         Abstract available
    
    
48. MAZET R, Torossian N, Wanneveich M, Metrard G, et al
    Calcium scoring during 18F-FDG PET/CT in cancer indications: Improving cardiovascular risk stratification and prevention.
    PLoS One. 2025;20:e0335249.
    PubMed         Abstract available
    
    
49. FONSECA FA, Caixeta A, Szarf G, Pinto I, et al
    Smaller infarct size with ticagrelor vs. clopidogrel in STEMI patients: Insights from cardiac magnetic resonance.
    PLoS One. 2025;20:e0328114.
    PubMed         Abstract available
    
    
50. BERGO KK, Norden ES, Bendiksen BA, Espe EKS, et al
    Sacubitril/valsartan preserves kidney function in rats with cardiorenal syndrome after myocardial infarction.
    PLoS One. 2025;20:e0335214.
    PubMed         Abstract available
    
    
51. ZHANG Z, Yue G, Wang L
    Analysis of disease burden and future trends of ischemic heart disease in China and globally, 1990-2023.
    PLoS One. 2025;20:e0333927.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.